Bioceres Crop Solutions Corp.

Welcome to today's BioService Crop Solutions Fiscal Second Quarter 2025 Financial and Operational Results. My name is Nandija and I will be your moderator for today's call. All lines will be muted during the presentation with an opportunity for questions and answers at the end. If you would like to ask a question, please press star one on your telephone keypad. I would now like to pass the conference over to your host, Paola Savanti, Head of Investor Relations. Please go ahead.

Thank you and good morning to everyone. Welcome to BioService Crop Solutions second quarter 2025 earnings conference call. Our prepared remarks today will be led by our Chief Executive Officer Federico Trucco and our Chief Financial Officer Enrique Lopez Lecube. Both of them will be available for the Q&A session following the presentation. During this call, we will make forward-looking statements. These statements are based on current expectations and assumptions that are subject to various risks and uncertainties. I refer you to the forward-looking statement section of the earnings release and presentation, as well as the recent filings with the SEC. We assume no obligation to update or revise any forward-looking statements to reflect new or changed circumstances. Please note in today's presentation, we'll be making references also to certain non-GAAP financial measures. Reconciliations of the non-GAAP measures can be found in our earnings press release. The conference call is being webcast and the webcast link is available at our investor relations website. It is now my pleasure to turn over the call to Federico.

Thank you, Paula, and good morning to everyone. Thank you for participating in today's call. Please turn to slide number three. Calendar year 2024 has been a reminder that growth, at least in our industry, the agricultural industry, is rarely linear. The conditions in Argentina, which remains our primary market, have proven increasingly difficult, as we have briefly discussed in our earnings pre-announcement of last week. Our revenues in the quarter declined by 24% compared to the year-ago quarter, And while we have improved our gross margins, our profitability metrics have been affected by this significant drop in the top line. Enrique will discuss our second quarter 25 and first half 25 numbers in more detail in a minute. And while it is important to note that we have roughly kept or increased market share in our key product segments, We also believe that we need to more effectively unlock the full potential commercially of our differentiated portfolio of products and technologies. To that end, we are implementing two important changes. First, in the seed segment, during our last call, we indicated that we were in the process of finalizing a strategy review with two key focal points. accelerating the transition to a more capital-like business model and exploring alternative monetization approaches. As a result of this process, we have made the strategic decision to exit breeding, seed production and seed commercialization and will instead partner with leading seed companies as well as some of our most important seed clients who are better structured to conduct these activities for us. Aligned with this new strategy, we are announcing a new agreement with GDM in soybeans and a revised partnership with Florimont de Pré in wheat, which I will describe later in the call. Second, we're appointing Milen Marinov, who previously served as our Executive VP of Commercial for North America, as our new Chief Commercial Officer. Milan's past experience in key commercial development roles, as well as his track record with us since joining the team last year, positioned him uniquely to help us streamline our commercial operations, accelerate the onboarding of new commercial partners, and better prioritize, diversify, and synchronize our portfolio opportunities for profitable growth. Before we discuss these changes in greater depth, I would like to pass over the call to Enrique for a discussion of our financial performance.